3rd Alpine Winter Conference on Medicinal and Synthetic Chemistry

 St. Anton, Austria    January 30-February 3, 2022

Keynote Speakers

Title to be announced

Prof. Angela KOEHLER
MIT KOCH INSTITUTE FOR INTEGRATIVE CANCER RESEARCH, Cambridge, United States

Functionalization of N-Heterocycles using Li, Mg, and Zn Organometallics

Prof. Paul KNOCHEL
LUDWIG MAXIMILIANS UNIVERSITY, Munich, Germany
Read more

Title to be announced

Dr Wendy YOUNG
GENENTECH, South San Francisco, United States

Automation and Machine Learning Applications for Medicinal Chemistry

Enabling Fragment-based Drug Discovery (FBDD) with Automated Synthesis Technologies

Dr Rachel GRAINGER
ASTEX PHARMACEUTICALS, Cambridge, United Kingdom
Read more

Rapid Development of Robust Reactions and Multi-Step Syntheses

Prof. Alexei LAPKIN
UNIVERSITY OF CAMBRIDGE, Cambridge, United Kingdom
Read more

Covalent Targeting: Innovating for the Future

Studies with Cyanamide-Based Janus Kinase 3 (JAK3) Covalent Inhibitors

Dr Agustin CASIMIRO-GARCIA
PFIZER, United States
Read more

Title to be announced

Dr Matthew CHEESEMAN
THE INSTITUTE OF CANCER RESEARCH, Sutton, United Kingdom

Reversible-covalent Inhibitors of the Kinase Activity of FGFR4

Dr Robin FAIRHURST
NOVARTIS, Basel, Switzerland
Read more

Increasing sp3 Fragment Options: Advances in the Synthesis of Small Ring Systems

Exploring and exploiting propellanes

Prof. Ed ANDERSON
UNIVERSITY OF OXFORD, Oxford, United Kingdom
Read more

The Next Generation of BCPs: Exploring Substitutions on the Bridge

Dr Xiaoshen MA
MERCK & CO., INC, Boston, United States
Read more

Synthesis and Functionalization of Cyclopropane Derivatives

Dr Sophie ROUSSEAUX
UNIVERSITY OF TORONTO, Toronto, Canada
Read more

Dearomative Functionalizations: From Simple Arenes to Complex Molecules

Dr David SARLAH
UNIVERSITY OF ILLINOIS, Urbana, United States
Read more

Methodologies to Understand Cellular Target Interaction

Intracellular Oligonucleotide Distribution and Protein Binding

Dr Alice GHIDINI
ASTRAZENECA, Gothenburg, Sweden
Read more

Lessons in Transcellular Membrane Permeability Re-Learned

Dr Mike HANN
GSK MEDICINES RESEARCH CENTRE, Stevenage, United Kingdom
Read more

Molecular Chameleonicity and Cell Permeability of Drugs and PROTACs in the bRo5 Space

Prof. Jan KIHLBERG
UPPSALA UNIVERSITY, Uppsala, Sweden
Read more

Title to be announced

Dr Anna RUTKOWSKA-KLUTE
GSK, Germany

Targeting Unstructured Proteins

Innovative Strategies to Target Non-Coding RNAs with Synthetic Ligands

Dr Maria DUCA
UNIVERSITY OF CÔTE D'AZUR, Nice, France
Read more

Design and Discovery of Clinical Candidate eFT226, a First-in-Class Inhibitor of the RNA Helicase eIF4A

Dr Christian NILEWSKI
GENENTECH, South San Francisco, United States
Read more

Drugging RNA – A Structure-based Approach

Dr Jennifer PETTER
ARRAKIS THERAPEUTICS, Waltham, United States
Read more

Title to be announced

Dr Nicolas THOMÄ
FRIEDRICH MIESCHER INSTITUTE FOR BIOMEDICAL RESEARCH, Basel, Switzerland

The "Catalytic Cycle" of Complex Molecule Synthesis and Methodology Development

Title to be announced

Prof. Tanja GAICH
UNIVERSITY OF KONSTANZ, Konstanz, Germany

Title to be announced

Prof. Ang LI
SHANGHAI INSTITUTE OF ORGANIC CHEMISTRY, Shanghai, China

Title to be announced

Prof. Ruben MARTIN
INSTITUTE OF CHEMICAL RESEARCH OF CATALONIA, Tarragona, Spain

Computationally Augmented Total Synthesis

Dr Timothy NEWHOUSE
YALE UNIVERSITY, New Haven, United States
Read more

Understanding PK and PK/PD relationships in drug discovery - Target Mediated Drug Disposition

Understanding the PKPD and ADME of PF-07059013: An Allosteric Modulator of a High Abundance Target

Dr Kevin BEAUMONT
ASTRAZENECA, Cambridge, United Kingdom
Read more

Basic Concepts in TMDD

Mr David FAIRMAN
GSK, Cambridge, United Kingdom
Read more